Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
51 participants
INTERVENTIONAL
2014-07-31
2015-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Native Kidney Denervation in Patients With End Stage Renal Disease
NCT00551304
Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension
NCT00753116
Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease
NCT02021019
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study
NCT04264403
Multi-electrode Radiofrequency Renal Denervation System Feasibility Study
NCT01699529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Renal denervation
Patients will be treated with the OneShot ablation system
OneShot Ablation System
Renal denervation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OneShot Ablation System
Renal denervation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is ≥ 18 years old.
* Patient provided written informed consent.
Exclusion Criteria
* Patients who have only one functioning kidney.
* Allergy to contrast or known hypersensitivity to device materials
* Patients with renal arteries \< 4 mm in diameter.
* Patients whose life expectancy is less than the planned period of study involvement.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Endovascular
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital San Raffaele
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP1002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.